| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 09/10/2002 | US6448278 Antiscarring agent |
| 09/10/2002 | US6448263 Synthesis routes for such as 2-amino-n-(2-(3a-(r)-benzyl-2-methyl-3-oxo-2,3,3a,4,6,7-hexahydro-pyrazolo -(4,3-c) pyridin-5-yl)-1-(r)-benzyloxymethyl-2-oxo-ethyl)-isobutyramide l-tartaric acid salt |
| 09/10/2002 | US6448229 Gamma secretase inhibitors |
| 09/10/2002 | US6448228 Functionalized oligopeptide having high fungicidal activity; one or two aliphatic amino acids such as valine, leucine and isoleucine, conjugated to one or two aromatic amino acids, such as phenyl-glycine, phenylalanine and beta-phenylalanine |
| 09/10/2002 | US6448031 Catalyzed by chymotrypsin in a reaction medium comprising 1-butanol |
| 09/10/2002 | US6448006 Methods and compositions for reducing bacterial tolerance to antibacterials disinfectants and organic solvents |
| 09/10/2002 | US6447766 Deamidated chemokines |
| 09/10/2002 | CA2258661C Synthetic phosphopeptides for treating bone diseases |
| 09/10/2002 | CA2239159C Acylated enol derivatives of .alpha.-ketoesters and .alpha.-ketoamides |
| 09/10/2002 | CA2129339C Inhibitors of thrombosis |
| 09/06/2002 | WO2002068601A2 Small peptides capable of modulating the function of cd66 (ceacam) family members |
| 09/06/2002 | WO2002068592A2 Non-racemic hexafluoreleucine, and methods of making and using it |
| 09/06/2002 | WO2002068586A2 Hiv/fiv protease inhibitors |
| 09/06/2002 | WO2002057225A3 Thrombin inhibitors |
| 09/06/2002 | WO2001064738A3 Heparin-binding amino acid sequences derived from human proteins facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 09/05/2002 | US20020123522 Inhibition of inflammation using interleukin-1beta-converting enzyme (ICE)/CED-3 family inhibitors |
| 09/05/2002 | US20020123498 For inhibiting transport protein; therapy |
| 09/05/2002 | US20020123468 Alpha-ketoamide inhibitors of hepatitis C virus NS3 protease |
| 09/05/2002 | DE10111161A1 Neue Siderophoranaloga als 4- oder 6-zähnige Eisenchelatoren auf der Basis von Aminosäuren oder Peptiden, Verfahren zu ihrer Herstellung und ihre Anwendung New Siderophoranaloga as 4- or 6-dentate iron chelators based on amino acids or peptides, process for their preparation and their use |
| 09/05/2002 | DE10106852A1 Entzündungshemmende Verbindungen Anti-inflammatory compounds |
| 09/04/2002 | EP1236713A1 Novel intermediate for sweetener with high sweetness and process for producing the same |
| 09/04/2002 | EP1235595A2 Integrin-mediated drug targeting |
| 09/04/2002 | EP0904095B1 Chimeric isoprenoid synthases and uses thereof |
| 09/04/2002 | EP0832104B1 Dolastatin derivatives, their preparation and use |
| 09/04/2002 | CN1367789A Synthesis of template-fixed beta-hairpin loop mimetics |
| 09/03/2002 | US6444817 Anticoagulants |
| 09/03/2002 | US6444811 Central nervous system disorders; cardiovascular disorders |
| 09/03/2002 | US6444678 α- and β-amino acid hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors |
| 09/03/2002 | US6444672 Heterocyclic derivatives and their use as antithrombotic agents |
| 09/03/2002 | US6444663 Treatment of patients suffering inflammatory, autoimmune and neurodegenerative diseases, and for the prevention of ischemic injury. |
| 09/03/2002 | US6444251 Artificial sweetening mixture |
| 09/03/2002 | CA2262816C Plant growth factor |
| 09/03/2002 | CA2079778C Inhibitors of thrombin |
| 08/29/2002 | WO2002066512A1 Angiogenesis-inhibitory tripeptides, compositions and their methods of use |
| 08/29/2002 | WO2002066497A2 Tetrapeptide regulating prostate functions and its compositions and methods |
| 08/29/2002 | WO2002066421A1 Rgd-analog non-peptidic molecules having anti-adhesive, anti-migration and anti-proliferative effects |
| 08/29/2002 | WO2002066046A1 Cancer therapeutic agent comprising thiopeptide with multiple thiazole rings |
| 08/29/2002 | WO2002065853A2 Catalyst modification to enhance neotame production |
| 08/29/2002 | WO2002020723A3 Compositions and methods for targeting peptides in humans in vivo |
| 08/29/2002 | WO2001095943A3 Prodrug compounds with an oligopeptide having an isoleucine residue |
| 08/29/2002 | WO2001000247A9 Peptide-lipid conjugates, liposomes and liposomal drug delivery |
| 08/29/2002 | US20020120100 Peptide transporters that specifically target certain cell types for the delivery of drugs and therapeutic agents |
| 08/29/2002 | US20020120099 Novel cyclic tetrapeptide derivatives and pharmaceutical uses thereof |
| 08/29/2002 | US20020120096 Capable of stably fixing a water-soluble polymer onto a surface structure by taking advantage of intermolecular interaction, thereby enabling the water-soluble polymer to be carried thereon without giving any damage |
| 08/29/2002 | US20020120009 Compounds and compositions for delivering active agents |
| 08/29/2002 | US20020119998 Oxadiazole, thiadiazoles or triazole metal derivatives reacted with an amine containing aldehyde, deprotecting, coupling with an acid and oxidizing to create substituted oxadiazole, thiadiazole or triazole peptoids |
| 08/29/2002 | US20020119992 Anticoagulants |
| 08/29/2002 | US20020119985 Serine protease inhibitors |
| 08/29/2002 | US20020119932 RGD-analog non-peptidic molecules having anti-adhesive, anti-migration and anti-proliferative effects |
| 08/29/2002 | US20020119153 Antibody conjugate formulations for selectively inhibiting VEGF |
| 08/29/2002 | CA2432932A1 Angiogenesis-inhibitory tripeptides, compositions and their methods of use |
| 08/28/2002 | EP1234834A1 1,3,4-oxadiazolin-2-one derivatives and drugs containing these derivatives as the active ingredient |
| 08/28/2002 | EP1234821A1 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient |
| 08/28/2002 | EP1234820A1 Oxadiazole derivatives and drugs containing these derivatives as the active ingredient |
| 08/28/2002 | EP1233789A2 Prodrugs of chemotherapeutic agents with oxaalkanoic acids |
| 08/28/2002 | EP1119528B1 Chemical constructs and their uses |
| 08/28/2002 | EP1084133B1 Redox reversible bipyridyl osmium complex conjugates |
| 08/28/2002 | EP0885189B1 Method for the synthesis of poly-pyrrole and poly-imidazole carboxamides on a solid support |
| 08/28/2002 | EP0846110B1 Thf-containing sulfonamide inhibitors of aspartyl protease |
| 08/27/2002 | US6441212 Silanol enzyme inhibitors |
| 08/27/2002 | US6441131 Peptides, method for assaying human pepsinogen II or human pepsin II, and assaying kit |
| 08/27/2002 | US6441130 Form triple stranded structures with nucleic acids |
| 08/27/2002 | US6441022 Use as hypolipidemic |
| 08/27/2002 | US6440955 Anti-inflammatory agents |
| 08/27/2002 | US6440939 Thrombin inhibitors |
| 08/27/2002 | US6440937 Competitive inhibitors of trypsin-like serin proteases, especially thrombin and kininogenases such as kallikrein; thrombin inhibitors, anticoagulants, and antiinflammatory agents |
| 08/27/2002 | US6440656 Methods for the inhibition of respiratory syncytial virus transmission |
| 08/27/2002 | CA2173939C Oligopeptides derived from c-reactive protein fragments |
| 08/27/2002 | CA2092733C Ltd4 receptor and photoaffinity probe |
| 08/22/2002 | WO2002064734A2 Identification of target-specific folding sites in peptides and proteins |
| 08/22/2002 | WO2002064623A1 Process for preparation of peptide derivatives |
| 08/22/2002 | WO2002064620A2 Metal-binding compounds and uses therefor |
| 08/22/2002 | WO2002064619A2 Peptides that inhibit poly-glutamine aggregation |
| 08/22/2002 | WO2002064559A2 Thrombin inhibitors |
| 08/22/2002 | WO2002064551A1 Hiv protease inhibitors based on amino acid derivatives |
| 08/22/2002 | WO2002064140A1 Thrombin inhibitors |
| 08/22/2002 | WO2002064131A2 Inflammation-inhibiting compounds |
| 08/22/2002 | WO2002064091A2 Melanocortin metallopeptides for treatment of sexual dysfunction |
| 08/22/2002 | WO2002008250A3 Ghrelin antagonists |
| 08/22/2002 | US20020115616 Inhibit beta-secretase to reduce beta amyloid peptide concentrations and reduce the amyloid plaques and neuro-fibrillary tangles; Alzheimer's disease; stroke; Down' syndrome; amyotrophic lateral sclerosis; brain disorders |
| 08/22/2002 | US20020115600 Inhibitors of memapsin 2 and use thereof |
| 08/22/2002 | US20020115103 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 08/22/2002 | CA2436789A1 Identification of target-specific folding sites in peptides and proteins |
| 08/22/2002 | CA2436176A1 Thrombin inhibitors |
| 08/22/2002 | CA2436068A1 Thrombin inhibitors |
| 08/21/2002 | EP1233021A2 An inhibitor of Beta amyloid cleavage enzyme |
| 08/21/2002 | EP1232253A2 Crystallizable compositions comprising a caspase-7 |
| 08/21/2002 | EP1232174A1 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 08/21/2002 | EP1232157A2 Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof |
| 08/20/2002 | US6437167 Chiral stationary phases for enantiomers separation and their preparation |
| 08/20/2002 | US6437121 Cationic lipids |
| 08/20/2002 | US6437094 Peptido-mimetic compounds containing RGD sequence useful as integrin inhibitors |
| 08/20/2002 | US6436980 Transport protein suppressors; microbiocides |
| 08/20/2002 | US6436969 Dialysis solutions and methods |
| 08/20/2002 | US6436904 Treatment of inflammatory diseases in mammals |
| 08/20/2002 | US6436903 Immunomodulating compounds comprising d-isomers of amino acids |
| 08/20/2002 | US6436697 Enzyme-mediated synthesis of peptidomimetics |
| 08/20/2002 | CA2216129C Lactam-containing hydroxamic acids |
| 08/20/2002 | CA2088367C Tri- and tetra-valent monospecific antigen-binding proteins |
| 08/15/2002 | WO2002062830A1 Tripeptide derivatives for the treatment of neurodegenerative diseases |